| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/21/2009 | EP2016953A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 01/21/2009 | EP2016951A1 Polypeptides homologous to VEGF and BMP1 |
| 01/21/2009 | EP2015778A1 Healing composition |
| 01/21/2009 | EP2015738A1 Use of a dermatological composition comprising a combination of hydroquinone, fluocinolone acetonide and tretinoin, for treating hyperpigmentation of pathological scars |
| 01/21/2009 | EP1487273B1 Compositions and methods for treatment of microbial infections |
| 01/21/2009 | EP0946155B2 Pharmaceutical composition for treating fecal incontinence |
| 01/21/2009 | CN101351466A Heterocyclic Janus kinase 3 inhibitors |
| 01/21/2009 | CN101351462A 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1(VR1) activity |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101348439A 6-substituted aryl -2-naphthoic acid derivative and preparation thereof |
| 01/21/2009 | CN101347617A Refined polyvalent anti-snake poison lyophilized blood serum and using method |
| 01/21/2009 | CN101347611A Medicine bag for treating beriberi |
| 01/21/2009 | CN101347596A External-use plaster for treating beriberi |
| 01/21/2009 | CN101347587A External-use Chinese medicine for treating itch and preparation method |
| 01/21/2009 | CN101347571A External-use plaster for treating mild skin burn |
| 01/21/2009 | CN101347563A Medicament for treating baldness and white hair and preparation method thereof |
| 01/21/2009 | CN101347561A External-use Chinese medicine for treating psoriasis and method for producing the same |
| 01/21/2009 | CN101347559A Medicament for treating ulcer of skin |
| 01/21/2009 | CN101347552A Fumigating agent for reducing fat and whitening skin and formulation and use method |
| 01/21/2009 | CN101347549A Medicament composition for treating intumescence and infection contamination of navel section of newborn infant as well as preparation method thereof |
| 01/21/2009 | CN101347546A Medicament composition for treating foot odor |
| 01/21/2009 | CN101347544A Chinese medicine for treating seborrheic baldness |
| 01/21/2009 | CN101347541A Medicament for treating gynecology disease and dermatopathy and preparation thereof |
| 01/21/2009 | CN101347538A Medicinal granules for fumigating and washing pudendum |
| 01/21/2009 | CN101347537A Medicinal granules of powder for dispelling toxicity of pudendum and production method |
| 01/21/2009 | CN101347536A External-use preparation for treating traumatic injury |
| 01/21/2009 | CN101347535A Regeneration plaster for burn and scald |
| 01/21/2009 | CN101347532A Spray for quick healing of burn |
| 01/21/2009 | CN101347531A External-use medical ointment for burn and scald |
| 01/21/2009 | CN101347515A Quick-acting antalgic plaster for detoxication and detumescence |
| 01/21/2009 | CN101347512A Macleaya cordata injection and preparation thereof |
| 01/21/2009 | CN101347499A Chinese medicine external-use medical ointment for treating innominate inflammatory and acariasis |
| 01/21/2009 | CN101347482A Ainsliaea fragrans extract and active component thereof as well as their quality control method |
| 01/21/2009 | CN101347472A Medicament for treating rotten sore of head section |
| 01/21/2009 | CN101347469A Composition containing extracts of Butyrospermum parkii and the use as medicament or dietary supplement |
| 01/21/2009 | CN101347452A Mesoporous calcium silica xerogel for treating skin ulcer and preparation and use thereof |
| 01/21/2009 | CN101347422A Uses of salvianolic acid A in preventing and/or treating diabetes and complication |
| 01/21/2009 | CN101347240A Health food |
| 01/21/2009 | CN101347158A Fresh flower cold tea for beauty treatment |
| 01/21/2009 | CN100453531C 半胱氨酸衍生物 Cysteine derivatives |
| 01/21/2009 | CN100453530C Compounds and methods for inhibition of expression of VCAM-1 |
| 01/21/2009 | CN100453092C Use of a lupeol-rich extract to make a pharmaceutical or cosmetic composition for treating or preventing degeneration of dermal, cartilage and/or gingival connective tissue |
| 01/21/2009 | CN100453090C Medicinal composition for treating burn and its preparing method |
| 01/21/2009 | CN100453089C Externally applied medicine for treating chilblain |
| 01/21/2009 | CN100453082C Compound terbinafine and root of large flowered skullcap cream and its preparing method |
| 01/21/2009 | CN100453073C Compound radical lobelia dripping pill and its preparing method |
| 01/21/2009 | CN100453070C Aseptic dry powder spray agent and production method in use for stopping the blood and diminishing inflammation in wound |
| 01/21/2009 | CN100453064C Chinese herbal medicine hot spring bath flake and powder and their preparing process |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479290 for preparing Solanum alkaloid glycosides; Solanum is subjected to methanol extraction, drying the extract and dissolving in a weak volatile acid and centrifuged, the supernatant is precipitated using a volatile base; high purity |
| 01/20/2009 | US7479287 Methods of inhibiting proliferation of cells |
| 01/20/2009 | US7479286 Microbiocides fatty acid mixed with feed |
| 01/20/2009 | US7479279 Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders |
| 01/20/2009 | CA2567575C Organo-gel formulations for therapeutic applications |
| 01/20/2009 | CA2423252C Photosensitisers |
| 01/20/2009 | CA2381261C Cosmetic and pharmaceutical compositions and methods using green-light emitting materials |
| 01/20/2009 | CA2364944C C16 unsaturated fp-selective prostaglandins analogs |
| 01/20/2009 | CA2348759C Gel compositions |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2271693C Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/17/2009 | CA2631685A1 Hair conditioning composition containing a non-guar galactomannan polymer derivative |
| 01/15/2009 | WO2009009417A2 Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion |
| 01/15/2009 | WO2009008318A1 Electrolytically reduced water, hot water for bathing, and method for suppression of lumpy fat |
| 01/15/2009 | WO2009007635A1 Chitosan carboxyalkylamide hydrogel, preparation thereof and cosmetic and dermatological use thereof |
| 01/15/2009 | WO2009007622A2 Dermatological composition containing calcitriol lipidic vesicles, method for preparing same and use thereof |
| 01/15/2009 | WO2009007412A2 Age deglycation |
| 01/15/2009 | WO2009007411A2 Inhibition of age formation |
| 01/15/2009 | WO2008137027A3 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation |
| 01/15/2009 | WO2008135661A3 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
| 01/15/2009 | WO2008131267A3 Low calcemic, highly antiproliferative, analogs of calcitriol |
| 01/15/2009 | WO2008064756A3 Use of substances reducing cellular glutathione content for producing a medicament for treating t-cell mediated autoimmune diseases |
| 01/15/2009 | WO2007119028A9 Composition including at least one aqueous phase and at least one fatty phase including ivermectin |
| 01/15/2009 | US20090018183 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/15/2009 | US20090018167 angiogenesis inhibitors such as 1-phenyl-3-pyridin-2-ylprop-2-en-1-one, having antitumor and anticarcinogenic activity; treatment of skin disorders such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, and lymphangiogenesis, as well as chronic inflammatory disease such as arthritis |
| 01/15/2009 | US20090018147 Compounds for modulating TRPV3 function |
| 01/15/2009 | US20090018138 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090018137 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018108 Treating skin hyperpigmentation with dermatological compositions comprising hydroquinone, fluocinolone acetonide and tretinoin |
| 01/15/2009 | US20090018102 Phamaceutical/cosmetic compositions comprising hyaluronic acid and treatment of dermatological conditions therewith |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018058 Vitamin D Receptor Modulators |
| 01/15/2009 | US20090017147 Cosmetic or Dermopharmaceutical Composition Comprising an Euglena Extract |
| 01/15/2009 | US20090017146 Beta Vulgaris-Based Products |
| 01/15/2009 | US20090017145 Tri ascorbate formulation |
| 01/15/2009 | US20090017144 Bioactive botanical cosmetic compositions and processes for their production |
| 01/15/2009 | US20090017141 Topical composition for the treatment of hyperpigmented skin |
| 01/15/2009 | US20090017129 Dead Sea minerals enriched anti-inflammatory pharmaceutical composition for treatment of cutaneous dryness, itching, peeling and tightness, especially in hemodialysis patients and preparation and treatment methods thereof |
| 01/15/2009 | US20090017104 Compositions containing retinoid and beta-aminoisobutyic acid derivatives |
| 01/15/2009 | US20090017078 Anhydrous topical formulation for polyphenols |
| 01/15/2009 | US20090017047 Preparation for the Prevention and Treatment of Stress Conditions as Well as Functional and Organic Disorders of the Nervous System and Metabolic Disorders |
| 01/15/2009 | US20090017030 Endothelial Cell Expression Patterns |
| 01/15/2009 | US20090017018 Uses of mammalian cytokine: related reagents |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | US20090016999 Embryonic cell compositions for wound treatment |
| 01/15/2009 | US20090016996 Hair mesenchymal cells |
| 01/15/2009 | US20090016994 in vitro growing of connective tissue substitute; method for closing of a wound wherein such connective tissue substitute is applied onto a wound; Artificial skin tissue |